Mark Niemaszek

Mark Niemaszek was named senior vice president of corporate planning for Urovant Sciences in October 2021. Mr. Niemaszek joined Urovant in 2020, as vice president of commercial operations. In his new role, he is responsible for driving the execution of the company’s geographic expansion plan. In addition, he is responsible for the Urovant enterprise-wise strategic plan, including leadership of the company’s long-range planning and budget process, infrastructure investment planning, and program integration.

Earlier in his career, he served as vice president of U.S. commercial operations for Astellas, where he led the development of enterprise capabilities for the Astellas Global business across a range of brands, sales teams, and business units. Earlier in his career, he led the accounting department, as well as the sales, marketing, and medical affairs operations for Fujisawa Pharmaceutical.

Mr. Niemaszek holds a Bachelor of Arts in finance/economics from St. Joseph’s College and an MBA in international business from Roosevelt/DePaul University.